ABBOT LABORATORIES HANDS LUPRON ACCOUNT TO LACROIX BLEAU
By Adnews Staff
The oncology division of Montreal's Abbott Laboratories has selcted Quebec advertising agency Lacroix Bleau to promote Lupron Deposit 4 Months, a new prostate cancer treatment taken three times a year. Lacroix Bleau beat out DKY of Montreal, which had also been invited to pitch for the account. Abbot first went to Lacroix Bleau in March for a national campaign supporting the launch of Synagis, a prescription drug that prevents respiratory syncitial virus in premature babies.
« Back Next »
Comments
blog comments powered by Disqus